GlobalData predicts the gMG market will grow from $6.1bn in 2024 to $10.5bn in 2034, with J&J's Imaavy set to bring in more than $300m in sales.
Researchers at the Penn State College of Medicine sought to determine the effects of Covid-19 and influenza on the risk of acute and chronic kidney disease.
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Combine proprietary data, human expertise, and purpose-built AI to uncover insights and accelerate better business decisions.
Discover our solutions
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
CinnaGen Enters EU Market with EMA Approval for Zandoriah®
Oncology trial systems debut at SCOPE 2026 as AI adoption accelerates
Biorce secures $52.5m in Series A to expand AI clinical trial tech
Revealing the human and business cost of clinical trial inefficiencies for Data Managers and CRAs